Trevi Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results
Trevi Therapeutics公布的第一季度GAAP每股收益低于预期后,该公司股价走低
Trevi Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results
Trevi Therapeutics公布的第一季度GAAP每股收益低于预期后,该公司股价走低
使用浏览器的分享功能,分享给你的好友吧